Skip to main content

Marsico Lung Institute Publications for August & September 2024

By

Marsico Lung Institute faculty, postdoc, student, and collaborator publications for August and September 2024 included papers appearing in Science Translational Medicine, Physical Review Letters, and European Respiratory Review. Check out the full list below:

  1. Curtis JL, Bateman LA, Murray S, Couper DJ, Labaki WW, Freeman CM, Arnold KB, Christenson SA, Alexis NE, Kesimer M, Boucher RC, Kaner RJ, Barjaktarevic I, Cooper CB, Hoffman EA, Barr RG, Bleecker ER, Bowler RP, Comellas A, Dransfield MT, Freedman MB, Hansel NN, Krishnan JA, Marchetti N, Meyers DA, Ohar J, O’Neal WK, Ortega VE, Paine Iii R, Peters SP, Smith BM, Wedzicha JA, Wells JM, Woodruff PG, Han MK, Martinez FJ. Design of the SPIROMICS Study of Early COPD Progression: SOURCE Study. Chronic Obstr Pulm Dis. 2024 Sep 27;11(5):444-459. doi: 10.15326/jcopdf.2023.0490. PMID: 39159077.
  2. Jain R, Peng G, Lee M, Keller A, Cosmich S, Reddy S, West NE, Kazmerski TM, Goralski JL, Flume PA, Roe AH, Hadjiliadis D, Uluer A, Mody S, Ladores S, Taylor-Cousar JL. Impact of Cystic Fibrosis Transmembrane Conductance Regulator Modulators on Maternal Outcomes During and After Pregnancy. Chest. 2024 Sep 27:S0012-3692(24)05275-9. doi: 10.1016/j.chest.2024.09.019. Epub ahead of print. PMID: 39343292.
  3. Liu CM, Fischer JL, Alt JA, Bodner TE, Chowdhury NI, Getz AE, Hwang PH, Kimple AJ, Mace JC, Smith TL, Soler ZM, Goss CH, Taylor-Cousar JL, Saavedra MT, Beswick DM. Impact of sinus surgery in people with cystic fibrosis and chronic rhinosinusitis in the era of highly effective modulator therapy: Protocol for a prospective observational study. PLoS One. 2024 Sep 26;19(9):e0310986. doi: 10.1371/journal.pone.0310986. PMID: 39325787; PMCID: PMC11426423.
  4. Mao Y, Suryawanshi A, Patial S, Saini Y. Airspaces-derived exosomes contain disease-relevant protein signatures in a mouse model of cystic fibrosis (CF)-like mucoinflammatory lung disease. Front Pharmacol. 2024 Sep 25;15:1460692. doi: 10.3389/fphar.2024.1460692. PMID: 39386033; PMCID: PMC11461968.
  5. Mall MA, Davies JC, Donaldson SH, Jain R, Chalmers JD, Shteinberg M. Neutrophil serine proteases in cystic fibrosis: role in disease pathogenesis and rationale as a therapeutic target. Eur Respir Rev. 2024 Sep 18;33(173):240001. doi: 10.1183/16000617.0001-2024. PMID: 39293854; PMCID: PMC11409056.
  6. Togami K, Wolf W, Olson LC, Card M, Shen L, Schaefer A, Okuda K, Zeitlin L, Pauly M, Whaley K, Pickles RJ, Lai SK. Impact of mAb-FcRn affinity on IgG transcytosis across human well-differentiated airway epithelium. Front Immunol. 2024 Sep 16;15:1371156. doi: 10.3389/fimmu.2024.1371156. PMID: 39351230; PMCID: PMC11439726.
  7. Vigil DL, Ge T, Rubinstein M, O’Connor TC, Grest GS. Measuring Topological Constraint Relaxation in Ring-Linear Polymer Blends. Phys Rev Lett. 2024 Sep 13;133(11):118101. doi: 10.1103/PhysRevLett.133.118101. PMID: 39331970.
  8. Cheng C, Katoch P, Zhong YP, Higgins CT, Moredock M, Chang MEK, Flory MR, Randell SH, Streeter PR. Identification of a Novel Subset of Human Airway Epithelial Basal Stem Cells. Int J Mol Sci. 2024 Sep 12;25(18):9863. doi: 10.3390/ijms25189863. PMID: 39337350; PMCID: PMC11432080.
  9. Choudhary I, Lamichhane R, Singamsetty D, Vo T, Brombacher F, Patial S, Saini Y. Cell-Specific Contribution of IL4 Receptor α Signaling Shapes the Overall Manifestation of Allergic Airway Disease. Am J Respir Cell Mol Biol. 2024 Sep 10. doi: 10.1165/rcmb.2024-0208OC. Epub ahead of print. PMID: 39254378.
  10. Thaxton C, Biesecker LG, DiStefano M, Haendel M, Hamosh A, Owens E, Plon SE, Rehm HL, Berg JS. Implementation of a dyadic nomenclature for monogenic diseases. Am J Hum Genet. 2024 Sep 5;111(9):1810-1818. doi: 10.1016/j.ajhg.2024.07.019. PMID: 39241757; PMCID: PMC11393707.
  11. Pudukodu H, Powell MZ, Ceppe A, Donaldson SH, Goralski JL, Sowa NA. Analysis of Depression and Anxiety Scores Following Initiation of Elexacaftor/Tezacaftor/Ivacaftor in Adults With Cystic Fibrosis. Clin Respir J. 2024 Sep;18(9):e70007. doi: 10.1111/crj.70007. PMID: 39210645; PMCID: PMC11362501.
  12. Hu P, Xiao H, Alba MA, Atkins HM, Gou S, Hu Y, Gomez JC, Jania CM, Martin JR, Morrison TE, Tilley SL, Heise MT, Doerschuk CM, Falk RJ, Jennette JC. Myeloperoxidase-ANCA IgG induces different forms of small vessel vasculitis based on type of synergistic immune stimuli. Kidney Int. 2024 Aug 30:S0085-2538(24)00628-8. doi: 10.1016/j.kint.2024.08.022. Epub ahead of print. PMID: 39216658.
  13. Rouillard KR, Jaspers I, Hill DB. Mucus matters: pollution alters mucus pathophysiology. Toxicol Sci. 2024 Aug 30:kfae082. doi: 10.1093/toxsci/kfae082. Epub ahead of print. PMID: 39212780.
  14. Clark J, Blake A, Vasher S, Boucher RC, Jones AR, Choi HJ, Albright BB. Near fatal case of mirvetuximab soravtansine-gynx induced interstitial lung disease and a review of the primary literature. Gynecol Oncol Rep. 2024 Aug 22;55:101486. doi: 10.1016/j.gore.2024.101486. PMID: 39281842; PMCID: PMC11399687.
  15. De C, Pickles RJ, Yao W, Liao B, Boone A, Cleary RA, Garcia JV, Wahl A. RSV infection of humanized lung-only mice induces pathological changes resembling severe bronchiolitis and bronchopneumonia. Front Virol. 2024 Aug 22;4:1380030. doi: 10.3389/fviro.2024.1380030. PMID: 39175804; PMCID: PMC11339974.
  16. Nguyen-Tran H, Spaulding AB, Messacar K, Vogt MR, Permaul P, Douek DC, Mittelman A, Thompson C, Grubbs S, Magana C, Hernandez ML. Recruitment and retention of pediatric participants for pandemic preparedness research: Experience from the PREMISE EV-D68 Pilot Study. Contemp Clin Trials Commun. 2024 Aug 14;41:101351. doi: 10.1016/j.conctc.2024.101351. PMID: 39252862; PMCID: PMC11381461.
  17. Plender EG, Prodanov T, Hsieh P, Nizamis E, Harvey WT, Sulovari A, Munson KM, Kaufman EJ, O’Neal WK, Valdmanis PN, Marschall T, Bloom JD, Eichler EE. Structural and genetic diversity in the secreted mucins MUC5AC and MUC5B. Am J Hum Genet. 2024 Aug 8;111(8):1700-1716. doi: 10.1016/j.ajhg.2024.06.007. PMID: 38991590. PMCID: PMC11344006.
  18. Warner NL, Archer J, Park S, Singh G, McFadden KM, Kimura T, Nicholes K, Simpson A, Kaelber JT, Hawman DW, Feldmann H, Khandhar AP, Berglund P, Vogt MR, Erasmus JH. A self-amplifying RNA vaccine prevents enterovirus D68 infection and disease in preclinical models. Sci Transl Med. 2024 Aug 7;16(759):eadi1625. doi: 10.1126/scitranslmed.adi1625. PMID: 39110777.

Filed Under:

Categories: News